Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
KRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.86 - $5.05
Previous CloseN/A
Volume31.78K
Average Volume (3M)84.91K
Market Cap
$181.70M
Enterprise Value$160.79M
Total Cash (Recent Filing)$8.05M
Total Debt (Recent Filing)$3.47M
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Nov 05, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding46,234,960
10 Day Avg. Volume71,170
30 Day Avg. Volume84,907
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue4.36
Enterprise Value/Gross Profit6.91
Enterprise Value/Ebitda-42.68
Forecast
1Y Price Target
$5.00Price Target Upside19.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceKRMD delivered a strong quarter as it generated $10M in quarterly revenues for the first time and beat across the P&L, continuing to see material outperformance in its OUS markets.
Market ExpansionContinued upside potential from OUS expansion into current and new markets as KRMD works to increase its market share internationally, including pre-filled syringe tender opportunities.
Product InnovationInnovation is alive and well including multiple expected 510(K) submissions in 2025 and 2026 across its core platform and Novel Therapies.
Bears Say
Market CompetitionKRMD is expanding its products with a next-gen pump and a new flow controller designed to open new global markets and accelerate revenue growth, reinforcing its competitive advantage in the SCIg market.
Product LaunchKRMD's new pump launching in the early part of 2026 should be supportive of KRMD winning more tenders as it is even more compatible with PFS than its current pump.
REPRO-MED Systems News
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $1.86 and its highest was $5.05 in the past 12 months.
What is REPRO-MED Systems’s market cap?
REPRO-MED Systems’s market cap is $181.70M.
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is Nov 05, 2025 which is in 26 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on Aug 06, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.022 by $0.032.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -0.02.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 46,234,960 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.022. Following the earnings report the stock price went up 18.712%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Currently, no hedge funds are holding shares in KRMD
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.00 (19.33% Upside)
$5.00 (19.33% Upside)
Blogger Sentiment
Bullish
KRMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.14%
12-Months-Change
Fundamentals
Return on Equity
-25.63%
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Company Description
REPRO-MED Systems
REPRO-MED Systems, Inc. (KRMD) is a medical technology company specializing in the development and manufacturing of innovative medical devices and solutions for the healthcare sector. The company focuses primarily on the area of infusion therapy, providing products that improve the delivery of medications to patients with chronic conditions. Its core products include the proprietary infusion pump system, the FREEDOM60, designed for subcutaneous drug delivery, and other related accessories. REPRO-MED Systems operates in the medical device sector, targeting patients requiring home healthcare solutions, as well as healthcare providers and institutions.
KRMD Company Deck
KRMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in revenue, international expansion, and positive developments in product pipelines and cash flow management. However, the gross margin decline and anticipated challenges with U.S. distributor inventory reductions present areas of concern. Overall, the positive aspects significantly outweigh the negatives.View all KRMD earnings summariesKRMD Stock 12 Month Forecast
Average Price Target
$5.00
▲(19.33% Upside)
Technical Analysis
InfuSystem Holdings
―
Orasure Technologies
―
Utah Medical Products
―
Microbot Medical
―
Sharps Technology, Inc.
―
Ownership Overview
17.94% Insiders
6.10% Mutual Funds
25.30% Other Institutional Investors
44.10% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---